Analysis of the Growth Dynamics of Angiogenesis-Dependent and -Independent Experimental Glioblastomas by Multimodal Small-Animal PET and MRI

Autor: Hrvoje Miletic, Krishna M. Talasila, Jian Wang, Frits Thorsen, Rolf Bjerkvig, Mathias Hoehn, Thomas Viel, Bernd Neumaier, Parisa Monfared, Alexandra Winkeler, Narve Brekka, Yannic Waerzeggers, Jan F. Jikeli, Heiko Backes, Daniel Stieber, Andreas H. Jacobs, Bertrand Tavitian, Simone P. Niclou
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Pathology
medicine.medical_specialty
Angiogenesis
Neovascularization
03 medical and health sciences
Rats
Nude

0302 clinical medicine
Methionine
In vivo
Fluorodeoxyglucose F18
Glioma
medicine
Image Processing
Computer-Assisted

Animals
Humans
Radiology
Nuclear Medicine and imaging

Paraffin Embedding
medicine.diagnostic_test
Neovascularization
Pathologic

business.industry
Brain Neoplasms
Magnetic resonance imaging
medicine.disease
Phenotype
Immunohistochemistry
Magnetic Resonance Imaging
Xenograft Model Antitumor Assays
Dideoxynucleosides
Rats
Ki-67 Antigen
Positron emission tomography
Blood-Brain Barrier
030220 oncology & carcinogenesis
Data Interpretation
Statistical

Positron-Emission Tomography
Disease Progression
medicine.symptom
Radiopharmaceuticals
business
Glioblastoma
030217 neurology & neurosurgery
Neoplasm Transplantation
Zdroj: Journal of Nuclear Medicine; Vol 53
ISSN: 0161-5505
DOI: 10.2967/jnumed.111.101659
Popis: The hypothesis of this study was that distinct experimental glioblastoma phenotypes resembling human disease can be noninvasively distinguished at various disease stages by imaging in vivo. Methods: Cultured spheroids from 2 human glioblastomas were implanted into the brains of nude rats. Glioblastoma growth dynamics were followed by PET using 18F-FDG, 11C-methyl-l-methionine (11C-MET), and 3′-deoxy-3′-18F-fluorothymidine (18F-FLT) and by MRI at 3–6 wk after implantation. For image validation, parameters were coregistered with immunohistochemical analysis. Results: Two tumor phenotypes (angiogenic and infiltrative) were obtained. The angiogenic phenotype showed high uptake of 11C-MET and 18F-FLT and relatively low uptake of 18F-FDG. 11C-MET was an early indicator of vessel remodeling and tumor proliferation. 18F-FLT uptake correlated to positive Ki67 staining at 6 wk. T1- and T2-weighted MR images displayed clear tumor delineation with strong gadolinium enhancement at 6 wk. The infiltrative phenotype did not accumulate 11C-MET and 18F-FLT and impaired the 18F-FDG uptake. In contrast, the Ki67 index showed a high proliferation rate. The extent of the infiltrative tumors could be observed by MRI but with low contrast. Conclusion: For angiogenic glioblastomas, noninvasive assessment of tumor activity corresponds well to immunohistochemical markers, and 11C-MET was more sensitive than 18F-FLT at detecting early tumor development. In contrast, infiltrative glioblastoma growth in the absence of blood–brain barrier breakdown is difficult to noninvasively follow by existing imaging techniques, and a negative 18F-FLT PET result does not exclude the presence of proliferating glioma tissue. The angiogenic model may serve as an advanced system to study imaging-guided antiangiogenic and antiproliferative therapies.
Databáze: OpenAIRE